Oncology Featured Articles
-
Clinical News Roundup: Can Clinical Trials On Pets Help People?
8/12/2016
Clinical news roundup for the week of August 8, 2016 with articles on using pets in clinical trials, the Quintiles/DaVita alliance, the benefits and pitfalls of data sharing, and the Orphan Drug Act.
-
Will Liquid Biopsies Transform Oncology Clinical Trials?
7/29/2016
Epic Sciences says it has developed a technology that CEO Murali Prahalad believes will transform oncology trials by identifying and characterizing circulating tumor cells. Those cells have been long recognized as a key part of cancer metastasis. Tumors shed these cells into the circulatory system where they then travel to different parts of the body and, under the right conditions, become the genesis of new tumors.
-
Why The Explosive Growth In Post-Approval Research?
7/26/2016
Post-approval research, also known as Phase 4 trials, is a segment of the clinical space that is growing very fast. Research shows that 13.7 percent of total R&D expenditure by pharmaceutical and biotechnology firms in 2014 was spent on conducting post-approval studies. In fact, post-approval research has been growing faster than any other area of clinical research.
-
Clinical Trials: A Winning Step Toward Medical Breakthroughs
7/25/2016
There is a direct correlation between innovations in modern medicine and clinical trials. Researchers and their sponsors continue to push what is possible with new forms of life-saving therapies enabled through cutting-edge science and good, old-fashioned trial and error. Modern medicines improve quality of lives. Clinical trials improve the quality of modern medicines.
-
Clinical News Roundup: GSK Uses Apple ResearchKit For Clinical Research
7/22/2016
Clinical news roundup for the week of July 18, 2016 featuring GSK's use of Apple ResearchKit, guidance on first-in-human clinical trials, clinical research transparency in India, nudging patients into clinical trials, and more.
-
Combining PROs And Clinical Data To Benefit Cancer Patients & Researchers
7/21/2016
Earlier this year PatientsLikeMe had the opportunity to collaborate with M2Gen in a real-world oncology study that combined clinical, molecular, and patient-reported data. This would help researchers develop more targeted treatments and help cancer patients better navigate treatment decisions.
-
Clinical News Roundup: Animal Testing To Transform Cancer Treatment In Humans
7/15/2016
Cancer treatment in humans could be transformed thanks to a study on treating cancer in animals led by researchers from the Ontario Veterinary College (OVC) at the University of Guelph. Medical Xpress reports the findings in mice and companion animals, such as cats, are already leading to clinical trials to treat people with various forms of cancer.
-
Clinical News Roundup: Should You Be Concerned About For-Profit Review Boards?
7/8/2016
Clinical News Roundup for the week of July 4, 2016 featuring for-profit institutional review boards, inefficiencies in clinical trials, smarter approaches to oncology trial design, clinical trial logistics, and integration between ClinicalTrials.gov and Drugs@FDA.
-
With Aspire, BMS Puts Focus On Clinical Sites And Patients
6/16/2016
Patient and site relationships are a primary concern to pharma and bio companies. The desire to be a sponsor of choice to both groups, as well as CRO partners, is suddenly a hot trend in the industry. Bristol-Myers Squibb saw both of these trends coming years ago, and has been taking steps to improve those relationships.
-
Genome Sequencing - The Key To The Cancer Moonshot?
6/10/2016
Though the announcement may seem recent, it was actually in October of last year when Vice President Biden boldly announced the “moonshot to cure cancer,” a personal passion fueled by his son’s death from the disease. Half a year later, this tall-order still has the industry – and world’s – attention, remaining the cause of consistent speculation and debate.